Pacific Biosciences' Q1 Net Loss Climbs as It Launches Sequencing Platform

The real-time, single-molecule sequencing technology firm reported $270,000 in grant revenue for the quarter. Its CEO said during a conference call that the company has an order backlog of 44 PacBio RS systems.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories